X7Q-15760-27666
2 vaccinations
4 coded responses
10 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 314 / GA
- Registered
- 2021-08-28
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-08-06
Dose 1 — Pfizer-BioNTech
-
2021-08-27
Dose 2 — Pfizer-BioNTech
-
2021-08-28
Registered in v-safe
-
2021-08-28
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Headache, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-08-29
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-08-30
Survey response — days 1–6 daily, dose 2MedDRA: Chest discomfort — Feeling: Good · HeadacheFree text: Chest heavyness with random tightnessMedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-08-31
- 2021-09-01
- 2021-09-10
- 2021-09-24
-
2021-10-08
Survey response — day 42, dose 2MedDRA: Breast swelling — Feeling: GoodFree text: Swollen left breastMedDRA releases: 2024-11 · check-in free text available
-
2021-11-27
Survey response — 3 months, dose 2MedDRA: Ectopic pregnancy, Salpingectomy — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, HospitalizationFree text: Ectopic pregnancy, surgical removal of fallopian tubeMedDRA releases: 2024-11 · check-in free text available
-
2021-11-27
Report sent to call center — 3 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prEmergency room or emergency department visit · Hospitalization · 1 call case(s)
- 2021-11-30
-
2022-08-27
Survey response — 12 months, dose 2MedDRA: Ectopic pregnancy, Menstrual disorder — Feeling: Fair · Be unable to work or attend schoolFree text: Ectopic pregnancy, worsening period problemsMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-08-06 | Pfizer-BioNTech | No |
| 2 | 2021-08-27 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-11-27 | Unsuccessful |
Free text
Release 9 — days 1–6 daily, dose 2
Systemic reaction (other): Chest heavyness with random tightness
Release 10 — day 42, dose 2
Symptoms: Swollen left breast
Release 10 — 3 months, dose 2
Symptoms: Ectopic pregnancy, surgical removal of fallopian tube
Release 12 — 12 months, dose 2
Symptoms: Ectopic pregnancy, worsening period problems
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Breast swelling | · | · | ✓ |
| SD | Ectopic pregnancy | · | · | ✓ |
| SD | Menstrual disorder | · | · | ✓ |
| SD | Salpingectomy | · | · | ✓ |
| SRO | Chest discomfort | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release